Key Stats for UnitedHealth Stock
- Price change for UnitedHealth stock: 5%
- $UNH Share Price as of Jun. 5: $396
- 52-Week High: $404
- $UNH Stock Price Target: $405
Now Live: Discover how much upside your favorite stocks could have using TIKR’s new Valuation Model (It’s free)>>>
What Happened?
UnitedHealth (UNH) stock popped nearly 6%, putting it on track for its best day since April.
The spark was a fresh vote of confidence from Wall Street.
Bank of America upgraded the stock to Buy from Neutral with a $450 target, and Morgan Stanley raised its target to $453, both citing lower medical utilization and a strong Q2 setup.
The move also helped UNH snap a five-day losing streak.
BofA analyst Kevin Fischbeck said the strong first quarter wasn’t just luck from a mild flu season and fewer storms.
He said incoming data makes it “more difficult to believe” the strong quarter was purely tied to those one-off factors.
The key driver is medical cost trends, with BofA’s own data showing lower utilization in April and May, which tends to be good news for managed care companies’ bottom lines.
See analysts’ growth forecasts and price targets for UnitedHealth stock (It’s free) >>>
What the Market Is Telling Us About UnitedHealth Stock
This was a clean signal that sentiment is turning. Two major firms made bullish calls on the same day, pointing to the same data.
The bigger story is medical costs.
- UnitedHealth makes money when it collects more in premiums than it pays out in claims.
- When people use less care, more of that premium drops to the bottom line.
- The company’s own results show the trend. In Q1, it posted adjusted EPS of $7.23, well ahead of expectations, and
- Raised its full-year outlook to more than $18.25 per share.
- Management is also leaning on pricing discipline and putting nearly $1.5 billion into AI to lower costs.
UnitedHealth stock had been beaten down hard, so this rebound carries weight. Even after the jump, UnitedHealth stock sits almost at its 52-week high and is up roughly 18% this year. That’s a sharp turnaround from a brutal 2025.
For long-term investors, UnitedHealth stock is starting to look like a recovery story, with the next big test being its Q2 results next month.
Estimate a company’s fair value instantly (Free with TIKR) >>>
How Much Upside Does UnitedHealth Stock Have From Here?
With TIKR’s new Valuation Model tool, you can estimate a stock’s potential share price in under a minute.
All it takes is three simple inputs:
- Revenue Growth
- Operating Margins
- Exit P/E Multiple
If you’re not sure what to enter, TIKR automatically fills in each input using analysts’ consensus estimates, giving you a quick, reliable starting point.
From there, TIKR calculates the potential share price and total returns under Bull, Base, and Bear scenarios so you can quickly see whether a stock looks undervalued or overvalued.
See a stock’s true value in under 60 seconds (Free with TIKR) >>>
Looking for New Opportunities?
- See what stocks billionaire investors are buying so you can follow the smart money.
- Analyze stocks in as little as 5 minutes with TIKR’s all-in-one, easy-to-use platform.
- The more rocks you overturn… the more opportunities you’ll uncover. Search 100K+ global stocks, global top investor holdings, and more with TIKR.
Disclaimer:
Please note that the articles on TIKR are not intended to serve as investment or financial advice from TIKR or our content team, nor are they recommendations to buy or sell any stocks. We create our content based on TIKR Terminal’s investment data and analysts’ estimates. Our analysis might not include recent company news or important updates. TIKR has no position in any stocks mentioned. Thank you for reading, and happy investing!
